Gsk Share Discussion Threads

[ianood] 17/1/2018 11:08

Polaris,Paul, Thank you for the benefit of your thoughts which are always most welcome. You have an extremely well informed analytical view and understanding which I assume comes from working within the pharma industry? I always used to appreciate your input on SKP in days of yore and now with VEC and GSK.

[tradermichael] 17/1/2018 08:44

Some would say that Emma is an outsider ..... ;0)

[ygor705] 17/1/2018 08:34

Some big buys went through late last night.......reinforces the trend. GSK's R&D budget is enormous and any trimming back will drop straight back into the P&L ........ management has options if it has the gumption/ability/resolve to look at them seriously. A large shake up required here or an outsider will come in and do it for them.

[dr biotech] 16/1/2018 20:23

Decent rise again stateside....never really seems to carry across though

[juju44] 16/1/2018 11:14

Nice bowl on the way back to 1500

[romeike] 16/1/2018 11:12

It is indeed. Trading the rise and fall between 1300 and 1700 very profitable over recent years.

[montyhedge] 16/1/2018 10:40

Even neutral 1580p so 1350p bargain, lol

[romeike] 16/1/2018 10:16

I agree Trader, around 1540p has been its usual anchor for a number of years now.

[tradermichael] 16/1/2018 08:50

Actually, its nearer 1525p if you trace back to the level that it plunged from after Emma's disasterous presentation..... ;0)

[montyhedge] 16/1/2018 08:13

1425p really the right price should settle down before the finals in a couple of weeks, 23p dividend expected.

[buywell3] 15/1/2018 18:49

What the author does not know is that the NHS estimated around 1 in 2000 people are now vCJD carriers from looking at thousands of appendix that were removed from patients


It has now been proved that this is on the low side and that different forms of CJD exist for which tests have never been carried out

Hence carriers could be around 1 in 900 people





CWD in Deer has spread to Norway and South Korea

hxxps://medicalxpress.com/news/2017-11-variant-creutzfeldt-jakob-disease.html

It continues to spread in the USA

[philanderer] 15/1/2018 18:12

Glaxo's Influenza Vaccine Gets FDA Nod for Label Expansion

[montyhedge] 15/1/2018 17:21

PhilThat would do me.

[ygor705] 15/1/2018 16:12

50 day moving average has just been broken and Cutler trend has been positive since October. The share price has also broken out of the top of its Bollinger range recently for the first time in ages. Momentum and sentiment improving here so I am in agreement with Monty - although it may take a little time to reach 1425.

[alphorn] 15/1/2018 10:54

#258. 200 patients; will be interesting all the same (as an observer).

[philanderer] 15/1/2018 10:48

15th jan Liberum buy tp 1760p

reiterates

[top tips] 15/1/2018 10:47

ImmuPharma end their Phase 3 Lupuzor trial this week and the results are expected to beat GSK's Benlysta.

[garycook] 15/1/2018 09:15

See your forecast of 1425p this week is looking good NOT.Put a sock in it.Your like an old women.Keep taking the tablets for your Bi-Polar condition.

[montyhedge] 15/1/2018 08:19

Health care sector weak today it seems.

[montyhedge] 12/1/2018 21:33

Dow on fire tonight, Monday watch GSK take off, bears are short and caught. Good weekend all.

[alphorn] 12/1/2018 20:10

Strong performance, especially taking account of forex moves.